Literature DB >> 30790138

Complementary and Integrative Medicine for Episodic Migraine: an Update of Evidence from the Last 3 Years.

Rebecca Erwin Wells1, Justin Beuthin2, Laura Granetzke2.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to evaluate evidence from the last 3 years on complementary and integrative medicine treatment options for episodic migraine. Using Pubmed, Embase, and Cochrane databases, research published from 2015-2018 evaluating the modalities of mind/body therapies, supplements, and manual therapies for treatment of migraine were assessed. RECENT
FINDINGS: Although many studies had major methodological challenges that limit interpretation, several studies reported decreased headache frequency, improved quality of life, or less affective responses to pain. The evidence is currently most promising for the mind/body treatment options of mindfulness, yoga, and tai chi. Mindfulness meditation may be as effective as pharmacological treatment for medication-overuse headache after the offending medication is withdrawn. While older research has shown magnesium, riboflavin, feverfew, and butterbur to be helpful in migraine treatment, new research is promising to suggest potential benefit with melatonin, vitamin D, higher dosages of vitamin B6 (80 mg)/folic acid 5 mg combinations, and the combination of magnesium 112.5 mg/CoQ10 100 mg/feverfew 100 mg. Omega 3s have limited evidence of efficacy in migraine. Butterbur needs to be free of pyrrolizidine alkaloids (PA) to ensure safety given their hepatotoxicity. Physical therapy (PT) continues to have strong evidence of support, and acupuncture is superior to sham acupuncture and placebo. Side effects and risks reported were minimal and well tolerated overall, with the exception of the life-threatening risk of cervical artery dissection with high-velocity chiropractic manipulation and hepatotoxicity with the PAs in butterbur. Several studies are ongoing to further evaluate mindfulness, melatonin, PT, exercise, chiropractic manipulation, and acupuncture. The American Academy of Neurology (AAN) and American Headache Society (AHS) are currently updating the guidelines for integrative treatment options for migraine, so additional recommendations may be available soon. In conclusion, many complementary and integrative treatment options may be helpful for patients with migraines, and understanding potential efficacy, benefits, and risks can help providers discuss these modalities with their patients. Such a conversation can empower patients, build the therapeutic relationship, and increase self-efficacy, thus improving outcomes and patient-centered care.

Entities:  

Keywords:  Acupuncture; Complementary and integrative medicine; Migraine; Mindfulness; Supplements

Mesh:

Year:  2019        PMID: 30790138      PMCID: PMC6559232          DOI: 10.1007/s11916-019-0750-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  16 in total

1.  Recruitment, retention, and adherence in a randomized feasibility trial of mindfulness-based stress reduction for patients with migraine.

Authors:  Heather Law; Andrew Avins; Robert Stahl; Michelle Goodreau; Alice Jacobson; Sylvia Sudat; Alice Pressman
Journal:  Complement Ther Med       Date:  2020-11-04       Impact factor: 2.446

Review 2.  Mindfulness in migraine: A narrative review.

Authors:  Rebecca Erwin Wells; Elizabeth K Seng; Robert R Edwards; David E Victorson; Charles R Pierce; Lauren Rosenberg; Vitaly Napadow; Zev Schuman-Olivier
Journal:  Expert Rev Neurother       Date:  2020-02-12       Impact factor: 4.618

3.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

4.  Unveiling the comparative efficacy and tolerability of comprehensive treatments for migraine: A protocol of systematic review and Bayesian network meta-analysis.

Authors:  Boru Jin; Huayan Liu; Lei Qiao
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 5.  A Bibliometric Analysis of Research Trends of Acupuncture Therapy in the Treatment of Migraine from 2000 to 2020.

Authors:  Tingting Zhao; Jing Guo; Yafang Song; Hao Chen; Mengzhu Sun; Lu Chen; Hao Geng; Lixia Pei; Jianhua Sun
Journal:  J Pain Res       Date:  2021-05-25       Impact factor: 3.133

Review 6.  Headache in people with epilepsy.

Authors:  Prisca R Bauer; Else A Tolner; Mark R Keezer; Michel D Ferrari; Josemir W Sander
Journal:  Nat Rev Neurol       Date:  2021-07-26       Impact factor: 42.937

7.  The Value of Headache-Specific Recommendations During COVID-19.

Authors:  Rebecca Erwin Wells; Lauren Doyle Strauss
Journal:  Headache       Date:  2020-05       Impact factor: 5.887

8.  The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.

Authors:  Zeinab Ghorbani; Pegah Rafiee; Akbar Fotouhi; Samane Haghighi; Reyhaneh Rasekh Magham; Zeynab Sadat Ahmadi; Mahmoud Djalali; Mahnaz Zareei; Soodeh Razeghi Jahromi; Sahar Shahemi; Maryam Mahmoudi; Mansoureh Togha
Journal:  J Headache Pain       Date:  2020-02-24       Impact factor: 7.277

9.  The Integrative Migraine Pain Alleviation through Chiropractic Therapy (IMPACT) trial: Study rationale, design and intervention validation.

Authors:  P M Wayne; C Bernstein; M Kowalski; J P Connor; K Osypiuk; C R Long; R Vining; E Macklin; P M Rist
Journal:  Contemp Clin Trials Commun       Date:  2020-01-22

10.  An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study.

Authors:  Mansoureh Togha; Soodeh Razeghi Jahromi; Zeinab Ghorbani; Amir Ghaemi; Pegah Rafiee
Journal:  BMC Neurol       Date:  2019-12-14       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.